// App-Quantinova.ai

: Exploring real-world outcomes with nivolumab plus chemotherapy in patients with advanced gastroesophageal adenocarcinoma.

Researchers

Presenter

  • Clara Chen

Principal Investigators

  • Ying Zhang

  • Min You

  • Eleni Theodorou

  • David Bertwistle

Medical Centers

  • Bristol Myers Squibb,London,United Kingdom

  • Bristol-Myers Squibb, Lawrenceville, NJ

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Nivolumab

  • Oxaliplatin, 5-fluorouracil and folic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved